SMNDC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.212800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.701200E-01
Normal-vs-Stage2
6.713200E-01
Normal-vs-Stage3
2.291600E-01
Normal-vs-Stage4
6.704200E-01
Stage1-vs-Stage2
5.497800E-01
Stage1-vs-Stage3
6.103400E-01
Stage1-vs-Stage4
2.270800E-01
Stage2-vs-Stage3
2.855400E-01
Stage2-vs-Stage4
2.588800E-01
Stage3-vs-Stage4
1.860360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.810000E-01
Normal-vs-AfricanAmerican
9.176200E-01
Normal-vs-Asian
6.457000E-01
Caucasian-vs-AfricanAmerican
3.418000E-01
Caucasian-vs-Asian
9.120400E-01
AfricanAmerican-vs-Asian
5.128200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.406000E-01
Normal-vs-Female
6.093000E-01
Male-vs-Female
9.939600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.969400E-01
Normal-vs-Age(41-60Yrs)
8.762000E-01
Normal-vs-Age(61-80Yrs)
4.246200E-01
Normal-vs-Age(81-100Yrs)
2.649200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.567600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.191000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.080800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.951000E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.688100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.459600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.601200E-01
Normal-vs-Daily Drinker
5.047200E-01
Normal-vs-Weekly Drinker
2.320400E-01
Normal-vs-Occasional Drinker
9.030600E-01
Normal-vs-Social Drinker
2.414800E-01
Non Drinker-vs-Daily Drinker
7.714800E-01
Non Drinker-vs-Weekly Drinker
4.860200E-01
Non Drinker-vs-Occasional Drinker
1.527420E-01
Non Drinker-vs-Social Drinker
6.335400E-01
Daily Drinker-vs-Weekly Drinker
7.035600E-01
Daily Drinker-vs-Occasional Drinker
1.174000E-01
Daily Drinker-vs-Social Drinker
8.685000E-01
Weekly Drinker-vs-Occasional Drinker
3.349600E-02
Weekly Drinker-vs-Social Drinker
7.772000E-01
Occasional Drinker-vs-Social Drinker
4.428400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.280600E-01
Normal-vs-Grade 2
4.535200E-01
Normal-vs-Grade 3
2.237800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.384000E-02
Grade 1-vs-Grade 3
5.117300E-03
Grade 1-vs-Grade 4
2.280600E-01
Grade 2-vs-Grade 3
2.527400E-01
Grade 2-vs-Grade 4
4.535200E-01
Grade 3-vs-Grade 4
2.237800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.756400E-01
Normal-vs-NonDiabetic
5.584000E-01
Diabetic-vs-NonDiabetic
7.434600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.264200E-01
Normal-vs-NoPancreatitis
5.621400E-01
Pancreatitis-vs-NoPancreatitis
3.525600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.744000E-01
Normal-vs-N1
6.767400E-01
N0-vs-N1
7.939200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.157800E-01
Normal-vs-TP53-NonMutant
3.450600E-01
TP53-Mutant-vs-TP53-NonMutant
3.956700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
